While treatment for inflammatory breast cancer has improved in recent years, it still carries a worse prognosis than many other forms of breast cancer. According to the American Cancer Society, the 5-year survival rate for inflammatory breast cancer is 40 percent, compared with 87 percent for all breast cancers.